Take Solutions Limited (TAKE) - Net Assets
Based on the latest financial reports, Take Solutions Limited (TAKE) has net assets worth Rs256.29 Million INR (≈ $2.77 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs352.13 Million ≈ $3.81 Million USD) and total liabilities (Rs95.84 Million ≈ $1.04 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check TAKE cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs256.29 Million |
| % of Total Assets | 72.78% |
| Annual Growth Rate | 10.65% |
| 5-Year Change | -98.17% |
| 10-Year Change | -96.94% |
| Growth Volatility | 90.64 |
Take Solutions Limited - Net Assets Trend (2002–2025)
This chart illustrates how Take Solutions Limited's net assets have evolved over time, based on quarterly financial data. Also explore how large is Take Solutions Limited's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Take Solutions Limited (2002–2025)
The table below shows the annual net assets of Take Solutions Limited from 2002 to 2025. For live valuation and market cap data, see how much is Take Solutions Limited worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs205.27 Million ≈ $2.22 Million |
+331.34% |
| 2024-03-31 | Rs-88.73 Million ≈ $-959.58K |
-108.17% |
| 2023-03-31 | Rs1.09 Billion ≈ $11.74 Million |
-39.87% |
| 2022-03-31 | Rs1.81 Billion ≈ $19.53 Million |
-83.93% |
| 2021-03-31 | Rs11.24 Billion ≈ $121.59 Million |
-29.08% |
| 2020-03-31 | Rs15.85 Billion ≈ $171.45 Million |
+3.80% |
| 2019-03-31 | Rs15.27 Billion ≈ $165.18 Million |
+14.27% |
| 2018-03-31 | Rs13.37 Billion ≈ $144.56 Million |
+40.24% |
| 2017-03-31 | Rs9.53 Billion ≈ $103.08 Million |
+41.94% |
| 2016-03-31 | Rs6.72 Billion ≈ $72.62 Million |
+15.68% |
| 2015-03-31 | Rs5.80 Billion ≈ $62.78 Million |
+11.99% |
| 2014-03-31 | Rs5.18 Billion ≈ $56.06 Million |
+11.21% |
| 2013-03-31 | Rs4.66 Billion ≈ $50.41 Million |
+22.80% |
| 2012-03-31 | Rs3.80 Billion ≈ $41.05 Million |
+34.67% |
| 2011-03-31 | Rs2.82 Billion ≈ $30.48 Million |
-26.90% |
| 2010-03-31 | Rs3.86 Billion ≈ $41.70 Million |
-0.07% |
| 2009-03-31 | Rs3.86 Billion ≈ $41.73 Million |
+29.28% |
| 2008-03-31 | Rs2.98 Billion ≈ $32.28 Million |
+237.07% |
| 2007-03-31 | Rs885.44 Million ≈ $9.58 Million |
+172.47% |
| 2006-03-31 | Rs324.97 Million ≈ $3.51 Million |
+135.28% |
| 2005-03-31 | Rs138.12 Million ≈ $1.49 Million |
+26.51% |
| 2004-03-31 | Rs109.18 Million ≈ $1.18 Million |
+44.94% |
| 2003-03-31 | Rs75.33 Million ≈ $814.67K |
+276.65% |
| 2002-03-31 | Rs20.00 Million ≈ $216.29K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Take Solutions Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 633196000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Rs146.22 Million | 71.23% |
| Other Comprehensive Income | Rs122.39 Million | 59.62% |
| Other Components | Rs6.27 Billion | 3053.84% |
| Total Equity | Rs205.27 Million | 100.00% |
Take Solutions Limited Competitors by Market Cap
The table below lists competitors of Take Solutions Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Grodno S.A.
WAR:GRN
|
$67.52 Million |
|
Zakłady Lentex SA
WAR:LTX
|
$67.53 Million |
|
Globe Metals & Mining Ltd
AU:GBE
|
$67.53 Million |
|
Complete Solaria, Inc
NASDAQ:SPWR
|
$67.57 Million |
|
Nestcon Bhd
KLSE:0235
|
$67.48 Million |
|
Wiable Corp
KQ:065530
|
$67.43 Million |
|
Fuzetec Technology Co Ltd
TWO:6642
|
$67.40 Million |
|
TECO Image Systems Co Ltd
TWO:5438
|
$67.36 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Take Solutions Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -88,730,000 to 205,270,000, a change of 294,000,000.
- Net income of 374,670,000 contributed positively to equity growth.
- Dividend payments of 390,000 reduced retained earnings.
- Other comprehensive income decreased equity by 5,030,000.
- Other factors decreased equity by 75,250,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs374.67 Million | +182.53% |
| Dividends Paid | Rs390.00K | -0.19% |
| Other Comprehensive Income | Rs-5.03 Million | -2.45% |
| Other Changes | Rs-75.25 Million | -36.66% |
| Total Change | Rs- | % |
Book Value vs Market Value Analysis
This analysis compares Take Solutions Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 30.42x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 4.55x to 30.42x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-03-31 | Rs9.39 | Rs42.69 | x |
| 2008-03-31 | Rs26.49 | Rs42.69 | x |
| 2009-03-31 | Rs31.11 | Rs42.69 | x |
| 2010-03-31 | Rs30.48 | Rs42.69 | x |
| 2011-03-31 | Rs21.17 | Rs42.69 | x |
| 2012-03-31 | Rs28.42 | Rs42.69 | x |
| 2013-03-31 | Rs34.97 | Rs42.69 | x |
| 2014-03-31 | Rs39.10 | Rs42.69 | x |
| 2015-03-31 | Rs43.65 | Rs42.69 | x |
| 2016-03-31 | Rs51.96 | Rs42.69 | x |
| 2017-03-31 | Rs71.22 | Rs42.69 | x |
| 2018-03-31 | Rs100.61 | Rs42.69 | x |
| 2019-03-31 | Rs103.57 | Rs42.69 | x |
| 2020-03-31 | Rs107.73 | Rs42.69 | x |
| 2021-03-31 | Rs76.92 | Rs42.69 | x |
| 2022-03-31 | Rs12.38 | Rs42.69 | x |
| 2023-03-31 | Rs7.43 | Rs42.69 | x |
| 2024-03-31 | Rs-0.61 | Rs42.69 | x |
| 2025-03-31 | Rs1.40 | Rs42.69 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Take Solutions Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 182.53%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.78x
- Recent ROE (182.53%) is above the historical average (-3.94%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 4.32% | 3.32% | 0.95x | 1.36x | Rs-5.89 Million |
| 2005 | 21.09% | 10.05% | 1.42x | 1.47x | Rs14.68 Million |
| 2006 | 32.09% | 20.00% | 0.53x | 3.01x | Rs66.35 Million |
| 2007 | 38.98% | 18.14% | 0.70x | 3.05x | Rs245.66 Million |
| 2008 | 18.35% | 18.35% | 0.74x | 1.35x | Rs245.47 Million |
| 2009 | 14.47% | 16.10% | 0.65x | 1.38x | Rs166.71 Million |
| 2010 | 9.92% | 10.32% | 0.69x | 1.40x | Rs-2.92 Million |
| 2011 | 28.88% | 14.70% | 0.85x | 2.31x | Rs480.85 Million |
| 2012 | 25.03% | 12.16% | 0.95x | 2.17x | Rs513.83 Million |
| 2013 | 18.90% | 9.55% | 0.99x | 1.99x | Rs374.28 Million |
| 2014 | 12.34% | 7.11% | 0.95x | 1.83x | Rs109.95 Million |
| 2015 | 13.33% | 9.57% | 0.79x | 1.76x | Rs174.41 Million |
| 2016 | 18.95% | 11.62% | 0.85x | 1.92x | Rs565.25 Million |
| 2017 | 15.71% | 10.64% | 0.98x | 1.51x | Rs519.83 Million |
| 2018 | 12.08% | 10.11% | 0.86x | 1.39x | Rs276.27 Million |
| 2019 | 11.68% | 8.70% | 0.87x | 1.54x | Rs254.73 Million |
| 2020 | -0.78% | -0.56% | 0.89x | 1.58x | Rs-1.70 Billion |
| 2021 | -40.19% | -58.40% | 0.42x | 1.64x | Rs-5.64 Billion |
| 2022 | -432.08% | -119.86% | 0.53x | 6.76x | Rs-8.00 Billion |
| 2023 | -92.32% | -53.03% | 0.84x | 2.07x | Rs-1.11 Billion |
| 2024 | 0.00% | -182.33% | 0.74x | 0.00x | Rs-1.19 Billion |
| 2025 | 182.53% | 0.00% | 0.00x | 1.78x | Rs354.14 Million |
Industry Comparison
This section compares Take Solutions Limited's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $10,511,977,250
- Average return on equity (ROE) among peers: 7.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Take Solutions Limited (TAKE) | Rs256.29 Million | 4.32% | 0.37x | $67.51 Million |
| BALAXI PHARMACEUTICALS LIMITED (BALAXI) | $2.01 Billion | -1.19% | 0.28x | $15.90 Million |
| Blue Jet Healthcare Limited (BLUEJET) | $6.81 Billion | 23.48% | 0.26x | $833.96 Million |
| Concord Biotech Limited (CONCORDBIO) | $11.03 Billion | 15.86% | 0.19x | $1.29 Billion |
| Dishman Carbogen Amcis Limited (DCAL) | $55.49 Billion | 0.32% | 0.56x | $310.59 Million |
| Lyka Labs Limited (LYKALABS) | $-151.11 Million | 0.00% | 0.00x | $23.04 Million |
| SMS Lifesciences India Limited (SMSLIFE) | $1.94 Billion | 4.70% | 1.02x | $42.13 Million |
| Supriya Lifescience Limited (SUPRIYA) | $6.16 Billion | 24.66% | 0.19x | $604.83 Million |
| Zota Health Care LImited (ZOTA) | $803.57 Million | -7.18% | 0.97x | $430.12 Million |
About Take Solutions Limited
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services in life sciences and software and information technology in India. The company offers clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance and safety services backed by technology expertise. It also provides embed digital and employ mobile solutions for patient c… Read more